Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy for recurrent miscarriage.

J R Scott1

  • 1Department of Obstetrics and Gynaecology, University of Utah Medical Centre, 420 Chipeta Way, Suite 100, Salt Lake City, Utah 84108, USA. jscott@hsc.utah.edu

The Cochrane Database of Systematic Reviews
|January 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes.

IJTLD open·2024
Same author

Correction to: Characterization of host response, resorption, and strength properties, and performance in the presence of bacteria for fully absorbable biomaterials for soft tissue repair.

Hernia : the journal of hernias and abdominal wall surgery·2024
Same author

Optogenetic stimulation of striatal patches modifies habit formation and inhibits dopamine release.

Scientific reports·2021
Same author

What are the immunological and clinical implications of microchimerism?

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Safety of eliminating postpartum magnesium sulphate: intriguing but not yet proven.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Characterization of host response, resorption, and strength properties, and performance in the presence of bacteria for fully absorbable biomaterials for soft tissue repair.

Hernia : the journal of hernias and abdominal wall surgery·2017
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Immunotherapy treatments like leukocyte immunization and IVIG do not significantly improve live birth rates for women with recurrent miscarriages. These immunologic treatments showed no significant benefit over placebo in preventing further pregnancy loss.

Area of Science:

  • Reproductive Immunology
  • Obstetrics and Gynecology

Background:

  • Recurrent early pregnancy loss may stem from immunologic aberrations in some women.
  • Understanding the role of immune system dysfunction is crucial for managing recurrent miscarriages.

Purpose of the Study:

  • To evaluate the efficacy of leukocyte immunization and intravenous immune globulin (IVIG) in improving live birth rates.
  • To assess immunologic treatments for women experiencing unexplained recurrent miscarriages.

Main Methods:

  • Systematic review of randomized controlled trials identified from the Cochrane Pregnancy and Childbirth Group trials register.
  • Included trials focused on women with at least three prior miscarriages, excluding known non-immunologic causes.
  • Data from 19 high-quality trials were analyzed, including paternal cell immunization, third-party donor cell immunization, trophoblast membrane infusion, and IVIG.

Related Experiment Videos

Main Results:

  • No significant difference in live birth rates was observed between immunotherapy groups and placebo.
  • Paternal cell immunization (OR 1.05, 95% CI 0.75-1.47) and IVIG (OR 0.98, 95% CI 0.61-1.58) showed no significant benefit.
  • Third-party donor cell immunization (OR 1.39, 95% CI 0.68-2.82) and trophoblast membrane infusion (OR 0.40, 95% CI 0.11-1.45) also did not demonstrate significant improvements.

Conclusions:

  • Current evidence suggests that paternal cell immunization, third-party donor leukocytes, trophoblast membranes, and IVIG are not effective over placebo for preventing recurrent miscarriages.
  • Further research may be needed to explore alternative or refined immunologic strategies for recurrent pregnancy loss.